Medicago engaged by the Canadian Government to develop Ebola monoclonal...
QUEBEC, Oct. 29, 2015 /CNW Telbec/ - Medicago, a leading Canadian company in the development and production of plant-based therapeutics and vaccines, has been awarded a contract by the Public Health...
View ArticleMedicago awarded a contract by the U.S. Department of Health and Human...
QUEBEC CITY, Feb. 24, 2015 /CNW Telbec/ - Medicago, a leading company in the development and production of plant-based vaccines and therapeutics, announced today that it has received a task order from...
View ArticleMitsubishi Tanabe Pharma Completes Acquisiton of Medicago
OSAKA, Japan and QUEBEC CITY, Canada, Sept. 18, 2013 /CNW/ - Mitsubishi Tanabe Pharma Corporation (TSE: 4508) ("Mitsubishi Tanabe Pharma" or "MTPC") and Medicago Inc. (TSX: MDG) announced today the...
View ArticleMedicago Announces Receipt of Final Court Order and Regulatory Approvals for...
QUEBEC CITY, Sept. 12, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago" or the "Company"), a biopharmaceutical company focused on developing highly effective and competitive vaccines...
View ArticleMedicago Shareholders Approve Arrangement with Mitsubishi Tanabe Pharma...
QUEBEC CITY, Aug. 29, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago" or the "Company"), a biopharmaceutical company focused on developing highly effective and competitive vaccines...
View ArticleMedicago Inc. announces leading independent proxy firms recommend voting in...
QUEBEC CITY, Aug. 19, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary...
View ArticleMedicago Announces 2013 Second Quarter Financial Results
QUEBEC CITY, Aug. 9, 2013 /CNW/ - Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies...
View ArticleMedicago announces special meeting of shareholders to be held on August 29,...
QUEBEC CITY, July 31, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary...
View ArticleMedicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a...
QUÉBEC CITY, July 12, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary...
View ArticleImmune Design and Medicago Announce License Agreement and Collaboration to...
SEATTLE and QUEBEC CITY, June 27, 2013 /CNW/ - Immune Design, a leader in the field of therapeutic vaccines for cancer, infectious diseases and allergy, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a...
View ArticleMedicago successfully produces plant-based Rotavirus VLP vaccine candidate
-First successful plant-based Rotavirus VLP containing all 4 Major proteins--International Patent Application filed- QUEBEC CITY, June 20, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a...
View ArticleMedicago Granted Patent for Influenza Virus-Like Particles in Plants
QUEBEC CITY, June 17, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing...
View ArticleMedicago Shareholders Approve Arrangement with Mitsubishi Tanabe Pharma...
QUEBEC CITY, Aug. 29, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago" or the "Company"), a biopharmaceutical company focused on developing highly effective and competitive vaccines...
View ArticleMedicago Inc. announces leading independent proxy firms recommend voting in...
QUEBEC CITY, Aug. 19, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary...
View ArticleMedicago Announces 2013 Second Quarter Financial Results
QUEBEC CITY, Aug. 9, 2013 /CNW/ - Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies...
View ArticleMedicago announces special meeting of shareholders to be held on August 29,...
QUEBEC CITY, July 31, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary...
View ArticleMedicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a...
QUÉBEC CITY, July 12, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary...
View ArticleImmune Design and Medicago Announce License Agreement and Collaboration to...
SEATTLE and QUEBEC CITY, June 27, 2013 /CNW/ - Immune Design, a leader in the field of therapeutic vaccines for cancer, infectious diseases and allergy, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a...
View ArticleMedicago successfully produces plant-based Rotavirus VLP vaccine candidate
-First successful plant-based Rotavirus VLP containing all 4 Major proteins--International Patent Application filed- QUEBEC CITY, June 20, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a...
View ArticleMedicago Granted Patent for Influenza Virus-Like Particles in Plants
QUEBEC CITY, June 17, 2013 /CNW/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing...
View Article
![SennaRin – ADRENA (2024-05-15) [FLAC 24bit/48kHz]](http://getimg.link/images/2024/05/21/7446422.jpg)
